Blood Pressure · 2002 · 15 citations · 21 references
Life SciencesBiochemistryEndocrinologyMetabolic PhysiologyMetabolic RegulationNutritional PhysiologyBlood Pressure RegulationCardiovascular Molecular PhysiologyCardiovascular PhysiologyFructose MetabolismInsulin ResistanceInsulin Signaling In MetabolismAnimal Model EvaluationBlood PressureControl Group DesignInsulin Regulation Of Protein MetabolismMitogen-activated Protein Kinase KinaseNitric OxideProtein Kinase G SignalingProtein Kinase Inhibitors
A fructose-enriched diet induces an increase in blood pressure associated with metabolic alterations in rats. Our hypothesis was that an increase in protein kinase C (PKC) activation, reported in the acute period of fructose overload, and an impaired vessel's response to vasoactive substances contribute to maintain elevated blood pressure levels in the chronic period. The aims of this study were to investigate in this animal model of hypertension: (1) if the increase in PKC activation was also found in the chronic stage; (2) the involvement of nitric oxide and insulin in the vessel's response; and plasma atrial natriuretic factor and nitrites/nitrates (nitric oxide metabolites) behavior. We evaluated the effects of: PKC-stimulator 12,13-phorbol dibutyrate, phenylephrine, insulin, nitric oxide synthase-inhibitor NG-nitro-L-arginine methyl esther (L-NAME) and PKC-inhibitor Calphostin C on aortic rings responses of Sprague-Dawley rats: fructose-fed and control. The fructose-fed group showed higher contractility to 12,13-phorbol dibutyrate than the control group in aortic rings pre-incubated with insulin, and this difference disappeared with L-NAME. The response to phenylephrine in rings pre-incubated with Calphostin C was decreased in the fructose-fed group and increased with Calphostin C plus L-NAME. Fructose-fed rats showed higher levels of plasma atrial natriuretic factor and nitrites/nitrates than controls. In conclusion, chronic fructose feeding seems to develop an impaired response to insulin, dependent on nitric oxide, suggesting a PKC alteration. Vasorelaxant agents, such as atrial natriuretic factor and nitric oxide, would behave as compensatory mechanisms in response to high blood pressure.
21
Coated Charcoal Immunoassay of Insulin
Victor Herbert, Kam‐Seng Lau, Chester W. Gottlieb et al. · The Journal of Clinical Endocrinology & Metabolism · 1965 · 3K citations
Nitrite and nitrate determinations in plasma: a critical evaluation
Han Moshage, Bessel Kok, J.R. Huizenga et al. · Clinical Chemistry · 1995 · 1.1K citations
Fructose-induced insulin resistance and hypertension in rats.
In‐Sul Hwang, Helen Ho, Brian B. Hoffman et al. · Hypertension · 1987 · 890 citations
Nitric oxide release accounts for insulin's vascular effects in humans.
Urs Scherrer, D Randin, Péter Vollenweider et al. · Journal of Clinical Investigation · 1994 · 759 citations · Full text
Medicine, Endocrinology, Physiology +15
Toyoshi Inoguchi, Ruggero Battan, Eugene S. Handler et al. · Proceedings of the National Academy of Sciences · 1992 · 740 citations